Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.

Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.

Chalandon Y, Thomas X, Hayette S, et al.  Blood, 125:3 711,  Jun 2015

Randomized study showed that reduced-intensity chemotherapy combined with imatinib is associated with lower early mortality and higher CR rate compared to a standard chemotherapy-imatinib combination protocol in adults with Ph-positive acute lymphoblastic leukemia.

THE OFFICIAL JOURNAL OF ISH

UPCOMING EVENTS

Universidad Autonoma de Nuevo Leon, Hematology Service, Hospital Universitario Monterrey, México
E-Mail : dgomezalmaguer@gmail.com

This website is only for professional-level audience and health professionals
LookUs & Online Makale